Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
147.45B
Market cap147.45B
Price-Earnings ratio
19.60
Price-Earnings ratio19.60
Dividend yield
6.45%
Dividend yield6.45%
Average volume
54.46M
Average volume54.46M
High today
$25.94
High today$25.94
Low today
$25.85
Low today$25.85
Open price
$25.36
Open price$25.36
Volume
203.68K
Volume203.68K
52 Week high
$27.69
52 Week high$27.69
52 Week low
$20.92
52 Week low$20.92

Stock Snapshot

With a market cap of 147.45B, Pfizer(PFE) trades at $25.87. The stock has a price-to-earnings ratio of 19.60 and currently yields dividends of 6.5%.

During the trading session on 2026-02-04, Pfizer(PFE) shares reached a daily high of $25.94 and a low of $25.85. At a current price of $25.87, the stock is +0.1% higher than the low and still -0.3% under the high.

Trading volume for Pfizer(PFE) stock has reached 203.68K, versus its average volume of 54.46M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.

PFE News

Nasdaq 8h
Will the Market Crash in 2026? Here's What History Says and What to Do About It

Key Points There are fears that stocks are overvalued right now, and some data backs this up. This could lead to a market crash, though we can't be certain....

Will the Market Crash in 2026? Here's What History Says and What to Do About It
TipRanks 10h
Balanced Near-Term Pipeline Upside Versus Structural Profit Headwinds Keeps Pfizer at Hold

Analyst Geoff Meacham from Citi maintained a Hold rating on Pfizer and keeping the price target at $26.00. Geoff Meacham has given his Hold rating due to a com...

TipRanks 13h
Pfizer Earnings Call: Pipeline Strength Amid COVID Reset

Pfizer Inc ((PFE)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and p...

Analyst ratings

57%

of 28 ratings
Buy
39.3%
Hold
57.1%
Sell
3.6%

More PFE News

Benzinga 20h
Silver Surges Over 15%; Pfizer Earnings Top Views

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 0.19% to 49,316.23 while the NA...

Silver Surges Over 15%; Pfizer Earnings Top Views
The Motley Fool 20h
Pfizer Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. Feb. 3, 2026 at 10:00 a.m. ET Call participants Chairman and Chief Executive Officer — Albert Bourla Chief Scientific Officer —...

Pfizer Q4 2025 Earnings Call Transcript
The Motley Fool 20h
Why Pfizer Stock Dropped Today

Is Pfizer stock a buy at under 9x earnings? Yes. It is. Pfizer (PFE 3.00%) stock gave up 3.3% through 10:50 a.m. ET Tuesday despite delivering an earnings beat...

Why Pfizer Stock Dropped Today
Benzinga 23h
Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

On Tuesday, Pfizer Inc. (NYSE:PFE) shared topline data from a mid-stage study for a weight loss drug and reported fourth quarter earnings that beat consensus es...

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops
Investor's Business Daily 23h
Pfizer Dives After Reaffirming Its Modest Outlook And Providing An Obesity Update

Technology Pfizer Dives After Reaffirming Its Modest Outlook And Providing An Obesity Update Licensing Pfizer (PFE) stock toppled early Tuesday after the S&P 50...

Pfizer Dives After Reaffirming Its Modest Outlook And Providing An Obesity Update
MarketWatch 1d
Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Pfizer highlighted the performance of a weight-loss drug it acquired in last year's deal to buy Metsera. Pfizer on Tuesday hailed a study of a weight-loss drug...

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline
The Wall Street Journal 1d
Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Pfizer reported lower fourth-quarter sales as demand for its Covid-19 vaccine and antiviral drug continued to decline. Maxim Shemetov/Reuters Pfizer PFE 0.83 %...

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.